Regencell Bioscience Holdings Ltd (RGC) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 16 institutional investors hold a position in Regencell Bioscience Holdings Ltd (NASDAQ:RGC).

• The percentage of Regencell Bioscience Holdings owned by institutions changed from 0.1% in September 2025 to 0.1% in December 2025, marking a slight down trend.
• In percentage terms, this reflects as a holdings change of -2.49% quarter on quarter, and an unavailable change year over year.
• Among the 16 institutional holders of Regencell Bioscience Holdings, 10 added to their stakes while 4 trimmed their positions and 2 held steady.
• This class of investors decreased its holdings in Regencell Bioscience Holdings to 545.39K shares for the 13F-cycle ending December 2025, down by 13.90K shares quarter on quarter, and up 500.24K shares year over year.
• With 413.08K shares, GEODE CAPITAL MANAGEMENT, LLC commands the largest institutional position in Regencell Bioscience Holdings as of December 31, 2025, equating to 0.08% of the company.
• Among the most significant buyers of Regencell Bioscience Holdings during December 2025 were UBS Group AG (17.82K), XTX Topco Ltd (15.08K), Hudson Bay Capital Management LP (13.11K), EverSource Wealth Advisors, LLC (550), Quarry LP (468).
• Leading sellers of Regencell Bioscience Holdings stock in December 2025 included Squarepoint Ops LLC (25.24K), MORGAN STANLEY (16.42K), JANE STREET GROUP, LLC (13.12K), GEODE CAPITAL MANAGEMENT, LLC (6.89K).
• The top 10 institutional holders of Regencell Bioscience Holdings for the quarter ending December 2025 included GEODE CAPITAL MANAGEMENT, LLC (413.08K), JANE STREET GROUP, LLC (31.30K), Squarepoint Ops LLC (26.01K), MORGAN STANLEY (21.42K), UBS Group AG (18.20K), XTX Topco Ltd (15.08K), Hudson Bay Capital Management LP (13.11K), BlackRock, Inc. (4.87K), EverSource Wealth Advisors, LLC (550), Quarry LP (468).